Welcome to the KRAS Patient Gateway newsletter from LUNGevity Foundation.
Since the approval of KRAS drugs for second-line treatment of patients with KRAS G12C-positive NSCLC, the race is on to bring these drugs to the front line of treatment (where chemotherapy is still the norm).
Researchers are also working hard to expand the use of KRAS drugs to other mutations beyond G12C, such as G12D.
In this edition of the newsletter, you can read more about these efforts and future directions of KRAS treatment, as well as information about living well with lung cancer.
Research News
PharmaLive
Mirati, Amgen, Lilly and more race to the front line in KRAS-mutated NSCLC
Published Nov 27, 2023
MDPI
Targeted Therapies for Kirsten Rat Sarcoma (KRAS) G12C Mutant Metastatic Non-Small-Cell Lung Cancers
Published Nov 25, 2023
PharmaPhorum
AstraZeneca joins KRAS push in cancer with Chinese deal
Published Nov 23, 2023
Newsdirectory3
Advancements in KRAS Inhibitor Treatment for Cancer: A Look at the Latest Developments
Published Nov 21, 2023
MedPage Today
Targeting KRAS in NSCLC: Recent Progress and New Approaches
Published Oct 23, 2023
Targeted Oncology
Sabari Reviews KRAS G12C Inhibitors in NSCLC
Published Sep 13, 2023
Chester County Press | | Press Releases
KRYSTAL-1 Trial Finds that Adagrasib Demonstrates Durable Clinical Activity in Patients with KRAS G12C Mutations
Published Sep 10, 2023
Get Connected
Join us for the KRAS Virtual Meetup
It’s the easy way to build your community. Each month, you can connect with others who understand what it’s like to live with KRAS+ lung cancer. The next KRAS Virtual Meetup is happening on Wednesday, December 20, 2023, at 12 pm ET. Register for the KRAS Meetup to get a confirmation email with details about how to join the virtual meeting. Can’t make it? Don’t worry, there’s a full list of virtual meetups to fit your schedule.
Have You Seen?
Learn from Experts at Your Convenience
The International Lung Cancer Survivorship Conference is LUNGevity’s annual virtual conference (held in September) to inform patients and caregivers about the latest lung cancer research and treatments. The sessions have been recorded and are available for free viewing until December 21. Register today to access these informative sessions from lung cancer experts. Learn more here.
Finding (Mental) Peace this Holiday Season
The holidays are stressful enough without having to deal with lung cancer. This recorded webinar offers a discussion about the mental health challenges we face in the lung cancer community, including strategies for coping with holiday anxiety and season affective disorder. Watch it here.
Helpful Apps for People Living with Cancer
As mobile apps become more ingrained in our lives, it’s natural to look for ones that can help manage a cancer diagnosis. LUNGevity Foundation has assembled a list of helpful apps to consider as you navigate a diagnosis. Read it here.
What are the Phases of Clinical Trials?
Lung cancer clinical trials are carefully designed research studies to evaluate and learn more about new drugs and treatments. Clinical trials are often described as phase 1, 2, 3, or 4. These phases can help us understand the benefits and drawbacks of participating in a particular clinical trial. Join Marissa Fors, an oncology social worker with CancerCare, for a brief explanation of the phases of clinical trials. Watch it here.
…and so much more at the KRAS Patient Gateway.
If you were forwarded this email and you’d like to subscribe to this newsletter, you can sign up here.
If you need further assistance along your lung cancer journey, please email us at support@lungevity.org. Our team is always here to assist you.
